New Treatment for hATTR Amyloidosis
Michael Polydefkis discusses hereditary ATTR amyloidosis and the recently FDA-approved Alnylam's ONPATTRO™, which is the first and only treatment appr...
5266 articles
Michael Polydefkis discusses hereditary ATTR amyloidosis and the recently FDA-approved Alnylam's ONPATTRO™, which is the first and only treatment appr...
Patients who are seeking for a particular healthcare service don't always go for the cheapest option. Learn more on Health Professional Radio.
Ken Cahill, CEO of SilverCloud Health, discusses the care gap in treating mental illness worldwide, pointing specifically to regions like the UK and US,...
George Grunberger shares the results of the national Type 1 Diabetes (T1D) Unmet Needs Survey that was commissioned by The American Association of Clini...
Joel Tune, CEO of Enteris Biopharma, discusses their proprietary drug delivery technology (Peptelligence®) that allows medicines to be delivered orally...
Steve Parkinson, President and CEO of Lakewood-Amedex (a privately-held, clinical stage pharmaceutical company), discusses their development of a broad ...
Colette Courtion, Joylux Founder and CEO discusses vFit, a device designated as a Low-Risk General Wellness Product by the FDA, that is the world's firs...
Ellen Manos, a Doctor Advocate for JDS Therapeutics, discusses a dedicated line of natural, plant-based, nutraceutical products for non-hormonal treatme...
CEO of On Target Laboratories, Martin Low, discusses On Target's development of two new drugs: OTL78, for the treatment of prostate cancer that selectiv...
Bruce Levy, a Mayo Clinic orthopedic and sports medicine surgeon, and his wife Heather Levy have developed the first and only medical-grade privacy garm...